A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED, PARALLEL-GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF 2 DOSE REGIMENS (INTRAVENOUS/SUBCUTANEOUS AND SUBCUTANEOUS) OF TEV-48125 VERSUS PLACEBO FOR THE PREVENTION OF EPISODIC CLUSTER HEADACHE

Registry ID

TV48125-CNS-30056

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC

Start date

2017-09-06

Last update

2017-03-23

Conditions

• EPISODIC CLUSTER HEADACHE

Related clinical trials

• "A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LY2951742 IN PATIENTS WITH EPISODIC CLUSTER HEADACHE."

View on source registry